187 related articles for article (PubMed ID: 18477147)
1. Mast cells and transforming growth factor-beta expression: a possible relationship in the development of porphyria cutanea tarda skin lesions.
Lançoni G; Ravinal RC; Costa RS; Roselino AM
Int J Dermatol; 2008 Jun; 47(6):575-81. PubMed ID: 18477147
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
Lim HW
Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
[TBL] [Abstract][Full Text] [Related]
3. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
Ozbilgin MK; Inan S
Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice.
Matsui K; Nishikawa A
Clin Exp Allergy; 2005 Mar; 35(3):382-7. PubMed ID: 15784119
[TBL] [Abstract][Full Text] [Related]
5. Nasal mucosal immunoexpression of the mast cell chemoattractants TGF-beta, eotaxin, and stem cell factor and their receptors in allergic rhinitis.
Salib RJ; Kumar S; Wilson SJ; Howarth PH
J Allergy Clin Immunol; 2004 Oct; 114(4):799-806. PubMed ID: 15480318
[TBL] [Abstract][Full Text] [Related]
6. [Sclerodermatous changes in porphyria cutanea tarda: six cases].
Khayat R; Dupuy A; Pansé I; Bagot M; Cordoliani F
Ann Dermatol Venereol; 2013 Oct; 140(10):589-97. PubMed ID: 24090888
[TBL] [Abstract][Full Text] [Related]
7. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
[TBL] [Abstract][Full Text] [Related]
8. Porphyria cutanea tarda.
Khoo BP; Tay YK
Singapore Med J; 2000 Jun; 41(6):292-4. PubMed ID: 11109347
[TBL] [Abstract][Full Text] [Related]
9. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
To-Figueras J; Ozalla D; Mateu CH
Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438
[TBL] [Abstract][Full Text] [Related]
10. [Role of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schonlein purpura nephritis].
Zhang GP; Dang XQ; Yi ZW; He XJ; Zhang JJ; Wu XC; Mo SH
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):125-8. PubMed ID: 17448307
[TBL] [Abstract][Full Text] [Related]
11. The significance of histologic analysis of skin lesions in porphyria cutanea tarda. Light microscopy, electron microscopy, immunohistochemical and immunofluorescence analysis.
Krajnc I; Vizjak A; Hvala A; Jurcić V; Rozman B
Wien Klin Wochenschr; 1998 Oct; 110(18):651-4. PubMed ID: 9816639
[TBL] [Abstract][Full Text] [Related]
12. [Porphyria cutanea tarda and hepatitis C virus infection].
Held E; Petersen CS
Ugeskr Laeger; 1997 Feb; 159(9):1284-6. PubMed ID: 9072876
[TBL] [Abstract][Full Text] [Related]
13. [Correlation study of TGF beta expression in diethylnitrosamine-induced rat liver cancer and mast cells in its vicinity].
Zheng M; Ruan Y; Wu Z
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):463-5. PubMed ID: 11235564
[TBL] [Abstract][Full Text] [Related]
14. Effect of high fiber vegetable-fruit diet on the activity of liver damage and serum iron level in porphyria cutanea tarda (PCT).
Dabrowska E; Jabłońska-Kaszewska I; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():282-6. PubMed ID: 12211737
[TBL] [Abstract][Full Text] [Related]
15. Acute exposure of human skin to ultraviolet or infrared radiation or heat stimuli increases mast cell numbers and tryptase expression in human skin in vivo.
Kim MS; Kim YK; Lee DH; Seo JE; Cho KH; Eun HC; Chung JH
Br J Dermatol; 2009 Feb; 160(2):393-402. PubMed ID: 18795915
[TBL] [Abstract][Full Text] [Related]
16. Increased mast cell numbers in the sclerotic skin of porphyria cutanea tarda.
Torinuki W; Kudoh K; Tagami H
Dermatologica; 1989; 178(2):75-8. PubMed ID: 2924986
[TBL] [Abstract][Full Text] [Related]
17. [Porphyria cutanea tarda].
Bygum A; Brandrup F; Christiansen L; Petersen NE
Ugeskr Laeger; 2000 Apr; 162(14):2020-4. PubMed ID: 10815515
[TBL] [Abstract][Full Text] [Related]
18. Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea tarda.
Thomas CL; Badminton MN; Rendall JR; Anstey AV
Clin Exp Dermatol; 2008 Jul; 33(4):422-4. PubMed ID: 18498414
[TBL] [Abstract][Full Text] [Related]
19. [Scleroderma and porphyria cutanea tarda].
Tsukazaki N; Okada S; Yoshida H
Nihon Rinsho; 1995 Jun; 53(6):1463-7. PubMed ID: 7616663
[TBL] [Abstract][Full Text] [Related]
20. [Effect of chloroquine in porphyria cutanea tarda].
Herrero C; Muniesa A
Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
